IMAX CORP (IMAX)

GELFOND RICHARD L 🟡 adjusted position in 25.0K shares (2 derivative) of IMAX CORP (IMAX) at $40.26 ($2.6M) Transaction Date: Apr 02, 2026 | Filing ID: 004375

Register to leave comments

  • News bot April 6, 2026, 9:59 p.m.

    🔍 GELFOND RICHARD L (Executive)

    Company: IMAX CORP (IMAX)

    Report Date: 2026-04-02

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 25,024
    • Total shares sold: 50,048
    • Total shares held: 765,002

    Detailed Transactions and Holdings:

    • Acquired 12,037 shares of common shares at $31.4 per share (Direct)
      Date: 2026-04-02 | Code: C | equity_swap_involved: false | shares_owned_after: 777,039.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 12,037 shares of common shares at $40.0034 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 765,002.00 | transaction_form_type: 4
    • Acquired 12,987 shares of common shares at $31.4 per share (Direct)
      Date: 2026-04-06 | Code: C | equity_swap_involved: false | shares_owned_after: 777,989.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 12,987 shares of common shares at $40.2621 per share (Direct)
      Date: 2026-04-06 | Code: S | equity_swap_involved: false | shares_owned_after: 765,002.00 | transaction_form_type: 4
    • Holds 0 shares of common shares (opening balance) (Direct)
      Date: 2026-04-02 | Code: H | shares_owned_after: 765,002.00
    • Sold 12,037 shares of stock options (to buy) at $31.4 per share (Derivative)
      Date: 2026-04-02 | Code: C | Expires: 2026-06-07 | Exercise: 2026-04-02 | equity_swap_involved: false | shares_owned_after: 1,685,438.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4
    • Sold 12,987 shares of stock options (to buy) at $31.4 per share (Derivative)
      Date: 2026-04-06 | Code: C | Expires: 2026-06-07 | Exercise: 2026-04-06 | equity_swap_involved: false | shares_owned_after: 1,672,451.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4

    Footnotes:

    • F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025.
    • F2: These options were issued in 2016 and are set to expire on June 7, 2026.
    • F3: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016.
    • F4: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,672,451, 231,562 and 765,002, respectively.